CIK 0001617867 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Autonomix Medical, Inc.
Sign in to watch- Ticker
- AMIX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471607810
- Phone
- 832-277-7816
- Business address
- 21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS, TX, 77380
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-03 | Smith Trent N. CFO | Grant or award | +15,000 | 15,119 | ||
| 2026-09-03 | KLEMP WALTER V Director | Grant or award | +13,000 | 20,118 | ||
| 2026-09-03 | Bisson Lori Director | Grant or award | +13,000 | 13,119 | ||
| 2026-09-03 | Hauser Bradley CEO and President | Grant or award | +27,000 | 27,000 | ||
| 2025-08-11 | Hauser Bradley CEO and President | Returned to the company · Option (Right to buy) | −45,000 | 0 | ||
| 2025-08-11 | Capelli Christopher Director | Returned to the company · Option (Right to buy) | −3,750 | 0 | ||
| 2025-08-11 | KLEMP WALTER V Director | Returned to the company · Option (Right to buy) | −8,773 | 1,250 | ||
| 2025-08-11 | Bisson Lori Director | Returned to the company · Option (Right to buy) | −18,862 | 47,930 | ||
| 2025-08-11 | Bisson Lori Director | Returned to the company · Option (Right to buy) | −46,680 | 1,250 | ||
| 2025-08-11 | Smith Trent N. CFO | Returned to the company · Option (Right to buy) | −11,405 | 22,500 | ||
| 2025-08-11 | Smith Trent N. CFO | Returned to the company · Option (Right to buy) | −21,250 | 1,250 | ||
| 2024-06-21 | Bisson Lori Director | Grant or award · Option (Right to buy) | +377,221 | 1,335,821 | ||
| 2024-06-21 | KLEMP WALTER V Director | Grant or award · Option (Right to buy) | +175,452 | 200,452 | ||
| 2024-06-21 | Smith Trent N. CFO | Grant or award · Option (Right to buy) | +228,087 | 678,087 | ||
| 2024-06-18 | Robins David Andrew Director | Purchase · Warrant (Right to buy) | +103,990 | $0.00 | $104 | 110,240 |
| 2024-06-18 | BioStar Ventures III, L.P. 10% owner | Purchase · Warrant to Purchase Common Stock | +1,088,000 | $0.03 | $30K | 1,088,000 |
| 2024-06-17 | Hauser Bradley CEO and President | Grant or award · Option (Right to buy) | +900,000 | 900,000 |
Page 1 of 1 · 17 trades